Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Total 13F shares
-
4,234,235
-
Share change
-
-1,590,507
-
Total reported value
-
$10,372,895
-
Price per share
-
$2.45
-
Number of holders
-
35
-
Value change
-
-$6,125,369
-
Number of buys
-
17
-
Number of sells
-
17
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q1 2018
As of 31 Mar 2018 Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) had 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,234,235 shares of stock of the company.
Largest 10 holders included FMR LLC, ROYCE & ASSOCIATES LP, VANGUARD GROUP INC, STIFEL FINANCIAL CORP, Sio Capital Management, LLC, JPMORGAN CHASE & CO, Opus Point Partners Management, LLC, Alethea Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This table shows 35 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.